advertisement
Yang S 16
Showing records 1 to 16 | Display all abstracts from Yang S108334 Fourteen-Year Outcome of Angle-Closure Prevention with Laser Iridotomy in the Zhongshan Angle-Closure Prevention Study: Extended Follow-up of a Randomized Controlled Trial
Yuan Y
Ophthalmology 2023; 130: 786-794
107698 Single-cell transcriptomics-based multidisease analysis revealing the molecular dynamics of retinal neurovascular units under inflammatory and hypoxic conditions
Zhang Y
Experimental Neurology 2023; 362: 114345
108334 Fourteen-Year Outcome of Angle-Closure Prevention with Laser Iridotomy in the Zhongshan Angle-Closure Prevention Study: Extended Follow-up of a Randomized Controlled Trial
Wang W
Ophthalmology 2023; 130: 786-794
107698 Single-cell transcriptomics-based multidisease analysis revealing the molecular dynamics of retinal neurovascular units under inflammatory and hypoxic conditions
Yang X; Deng X
Experimental Neurology 2023; 362: 114345
108334 Fourteen-Year Outcome of Angle-Closure Prevention with Laser Iridotomy in the Zhongshan Angle-Closure Prevention Study: Extended Follow-up of a Randomized Controlled Trial
Xiong R
Ophthalmology 2023; 130: 786-794
107698 Single-cell transcriptomics-based multidisease analysis revealing the molecular dynamics of retinal neurovascular units under inflammatory and hypoxic conditions
Yang S
Experimental Neurology 2023; 362: 114345
108334 Fourteen-Year Outcome of Angle-Closure Prevention with Laser Iridotomy in the Zhongshan Angle-Closure Prevention Study: Extended Follow-up of a Randomized Controlled Trial
Zhang J
Ophthalmology 2023; 130: 786-794
107698 Single-cell transcriptomics-based multidisease analysis revealing the molecular dynamics of retinal neurovascular units under inflammatory and hypoxic conditions
Li Q
Experimental Neurology 2023; 362: 114345
108334 Fourteen-Year Outcome of Angle-Closure Prevention with Laser Iridotomy in the Zhongshan Angle-Closure Prevention Study: Extended Follow-up of a Randomized Controlled Trial
Li C; Yang S
Ophthalmology 2023; 130: 786-794
107698 Single-cell transcriptomics-based multidisease analysis revealing the molecular dynamics of retinal neurovascular units under inflammatory and hypoxic conditions
Xie Z
Experimental Neurology 2023; 362: 114345
108334 Fourteen-Year Outcome of Angle-Closure Prevention with Laser Iridotomy in the Zhongshan Angle-Closure Prevention Study: Extended Follow-up of a Randomized Controlled Trial
Friedman DS
Ophthalmology 2023; 130: 786-794
107698 Single-cell transcriptomics-based multidisease analysis revealing the molecular dynamics of retinal neurovascular units under inflammatory and hypoxic conditions
Hong L
Experimental Neurology 2023; 362: 114345
108334 Fourteen-Year Outcome of Angle-Closure Prevention with Laser Iridotomy in the Zhongshan Angle-Closure Prevention Study: Extended Follow-up of a Randomized Controlled Trial
Foster PJ
Ophthalmology 2023; 130: 786-794
107698 Single-cell transcriptomics-based multidisease analysis revealing the molecular dynamics of retinal neurovascular units under inflammatory and hypoxic conditions
Cao M; Yi G
Experimental Neurology 2023; 362: 114345
108334 Fourteen-Year Outcome of Angle-Closure Prevention with Laser Iridotomy in the Zhongshan Angle-Closure Prevention Study: Extended Follow-up of a Randomized Controlled Trial
He M
Ophthalmology 2023; 130: 786-794
107698 Single-cell transcriptomics-based multidisease analysis revealing the molecular dynamics of retinal neurovascular units under inflammatory and hypoxic conditions
Fu M
Experimental Neurology 2023; 362: 114345
